1H
|
One-way ANOVA followed by Tukey-Kramer multiple comparisons |
p = 0.045 and p = 0.0086 for Cluster 1 vs Cluster 2 and Cluster 2 vs Cluster 3, respectively, for the null hypothesis that the two means do not differ. |
2G
|
One-way ANOVA followed by Tukey-Kramer multiple comparisons |
p = 0.0008 for Tbx21 vs Lbhd2; p = 0.0035 for Tbx21 vs Pkib, respectively, for the null hypothesis that the two means do not differ. |
7E, left |
One-way ANOVA followed by Tukey-Kramer multiple comparisons |
p = 0.012 for Tbx21 vs Lbhd2 (1 × 80 mg/kg tamoxifen); 0.045 for Tbx21 vs Lbhd2 (3 × 80 mg/kg tamoxifen); 0.008 for Ra13 vs Lbhd2 (1 × 80 mg/kg tamoxifen); p = 0.029 for Ra13 vs Lbhd2 (3 × 80 mg/kg tamoxifen), each for the null hypothesis that the two means do not differ. |
7E, middle |
One-way ANOVA followed by Tukey-Kramer multiple comparisons |
p = 8.8 × 10−5 for Tbx21 vs Lbhd2 (1 × 80 mg/kg tamoxifen); 1.5 × 10−5 for Tbx21 vs Lbhd2 (3 × 80 mg/kg tamoxifen); 6.5 × 10−5 for Ra13 vs Lbhd2 (1 × 80 mg/kg tamoxifen); 1.2 × 10−5 for Ra13 vs Lbhd2 (3 × 80 mg/kg tamoxifen), each for the null hypothesis that the two means do not differ. |
7E, right |
One-way ANOVA followed by Tukey-Kramer multiple comparisons |
p = 3.4 × 10−5 for Tbx21 vs Lbhd2 (1 × 80 mg/kg tamoxifen); 1.1 × 10−4 for Tbx21 vs Lbhd2 (3 × 80 mg/kg tamoxifen); 2.3 × 10−4 for Ra13 vs Lbhd2 (1 × 80 mg/kg tamoxifen); 8.0 × 10−4 for Ra13 vs Lbhd2 (3 × 80 mg/kg tamoxifen), each for the null hypothesis that the two means do not differ. |